Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial-Reference-Cited by-同舟云学术

Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial

Published:2019-09 Issue: Volume:211 Page:103-104
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Rabinowitz Jonathan^ORCID,Badescu Stefan,Palamarchuk Pavel,Filyk Viktor,Voloshchuk Anatolii,Rud Vadym,Melnyk Ellina,Skrypnikov Andrii,Davidson Michael,Saoud Jay,Luthringer Remy

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference8 articles.

1. Efficacy and safety of MIN-101: a 12-week randomized, double-blind, placebo-controlled trial of a new drug in development for the treatment of negative symptoms in schizophrenia;Davidson;Am. J. Psychiatry,2017

2. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program;Kane;Am. J. Psychiatry,2016

3. Cognitive effects of MIN-101 in patients with schizophrenia and negative symptoms: results from a randomized controlled trial;Keefe;J Clin Psychiatry,2018

4. Small sample inference for fixed effects from restricted maximum likelihood;Kenward;Biometrics,1997

5. Minimal detectable change of the Personal and Social Performance scale in individuals with schizophrenia;Lee;Psychiatry Res.,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of prominent and predominant negative symptoms across different criteria for negative symptom severity and minimal positive symptoms: A comparison of different criteria;Schizophrenia Research;2024-09

2. Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia;Patient Related Outcome Measures;2024-06

3. Schizophrenia and disruption of circadian rhythms: An overview of genetic, metabolic and clinical signs;Schizophrenia Research;2024-02

4. Long-term effects of Roluperidone on negative symptoms of schizophrenia;Schizophrenia Research;2023-05

5. KARANTİN MƏHDUDİYYƏTİ ŞƏRAİTİNDƏ DEMENSİYALI PASİYENTLƏRƏ QULLUĞUN ÇƏTİNLİKLƏRİ;Azerbaijan Medical Journal;2023-03-15